Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Depakote(R) Delayed Release Tablets
Date:7/30/2008

ially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include, but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or cheaper products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, and other risks identified in this report and from time to time in our periodic reports and registration statements. These forward- looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.


'/>"/>
SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
3. Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008
4. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
5. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
6. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... According to Kxan ... the cycle of addiction in lab mice. The study involving isradipine has garnered national ... prospect of helping their clients overcome drug and alcohol addictions. The study was conducted ...
(Date:7/28/2015)... ... ... Bipolar disorder is often associated with mood swings ranging from depressive lows ... World Health Organization (WHO) has reported that bipolar disorder affects about 60 million people ... United States has the highest lifetime rate of bipolar disorder at 4.4% affecting 14 ...
(Date:7/28/2015)... ... July 28, 2015 , ... Safeguard Scientifics, Inc. (NYSE:SFE) (“the ... time to time and depending on market conditions, to repurchase shares of its ... will be made in open market or privately negotiated transactions in compliance with ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Fertility ... chosen as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top ... by hundreds of her esteemed colleagues and peers in the metro area as one ...
(Date:7/28/2015)... ... 28, 2015 , ... The PULs Cardiac Test™ identifies asymptomatic ... many of whom are missed by conventional evaluation , A currently unmet ... sub-clinical disease, who are at risk of experiencing a coronary event, and for ...
Breaking Medicine News(10 mins):Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2
... say risks of long-term use still outweigh possible benefits ... therapy once seemed like a wonderful means to help ... and progesterone as their bodies began to produce decreased ... fend off heart disease, osteoporosis and cancer. , But ...
... ... Immigration Conference and Job Fair Series includes events in New York on ... The annual series is free and provides a unique and educational opportunity ... and residency program directors and coordinators, who manage medical training programs at ...
... , , OAKLAND, Calif., Aug. ... their subsidiaries (KFHP/H) reported today a combined total operating revenue of ... $10.1 billion in the second quarter of last year. Operating ... in the second quarter of last year. Net non-operating income ...
... , , , ... WPI ), a leading specialty pharmaceutical company, announced today that ... the United States is being voluntarily recalled from wholesalers and pharmacies. ... dates of February 2011 and were manufactured by Watson Laboratories, Inc. ...
... on heavier children may miss the target, study finds ... testing guidelines for children may have to be revised, ... an effective indicator of high cholesterol in kids. , ... revised cholesterol screening guidelines that recommended a cholesterol check ...
... consumption to six cancers , FRIDAY, Aug. 7 (HealthDay News) ... alcohol over the course of his life appears to raise ... kinds of cancer, a new crunching of quarter-century-old research data ... more men drink, the greater their risk for specific cancers. ...
Cached Medicine News:Health News:In U.S., No Comeback Seen for Hormone Therapy 2Health News:In U.S., No Comeback Seen for Hormone Therapy 3Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 2Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 3Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Second Quarter 2009 Financial Results 4Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 3Health News:Cholesterol Screening Shouldn't Rely on Kids' Weight 2Health News:Drinking Moderately or More Ups Men's Cancer Risk 2Health News:Drinking Moderately or More Ups Men's Cancer Risk 3
(Date:7/28/2015)... , July 28, 2015  Cepheid (Nasdaq: ... a flexible and portable clinical molecular diagnostic system ... of Care market.  At just 9 inches tall, ... will run the same high quality PCR-based Xpert® ... enabling highly accurate clinical molecular diagnostic tests to ...
(Date:7/28/2015)... , July 20, 2015 ... addition of the "Global Post-traumatic Stress Disorder Therapeutics ... The global PTSD therapeutics market to grow at a ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:7/27/2015)... CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today ... financial results on Thursday, August 6, 2015, after the ... members of the management team will host a webcast ... general corporate update at 4:30 p.m. EDT (1:30 p.m. ... follows: Thursday, August 6 1:30 p.m. PDT/4:30 ...
Breaking Medicine Technology:World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Nov. 8, 2010 EXTENSION, INC . announced today ... will make available for general release to the healthcare community ... offerings use Cisco IP devices and smartphones as end points ... smartphone devices will not only serve as communication end points ...
... NYSE: SNY ) announced today that it has ... ) requesting that Genzyme clarify its position on a number ... Sanofi-aventis, letter also notes that it is encouraged by ... parties but observes that sanofi-aventis has not been contacted by ...
Cached Medicine Technology:EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows 2EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows 3Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions 2Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions 3Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions 4Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: